Adam Doern

Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR

Jennifer S. Michaelson, Stephen J. Demarest, Brian Miller et al. · mAbs · 2009 · 115 citations · Full text

Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response

Jianying Dong, Stephen J. Demarest, Arlene Sereno et al. · Molecular Cancer Therapeutics · 2010 · 58 citations

Immunology, Mtor Inhibitor Rapamycin, Enhanced Antitumor Response +16

Evaluation of Tyro3 Expression, Gas6-Mediated Akt Phosphorylation, and the Impact of Anti-Tyro3 Antibodies in Melanoma Cell Lines

Stephen J. Demarest, Jennifer Gardner, Michelle C. Vendel et al. · Biochemistry · 2013 · 47 citations

Immunology, Cell Death, Tyro3 Expression +18

Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity

Jianying Dong, Arlene Sereno, William B. Snyder et al. · Journal of Biological Chemistry · 2010 · 38 citations · Full text

Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties

Adam Doern, Xianjun Cao, Arlene Sereno et al. · Journal of Biological Chemistry · 2009 · 26 citations · Full text